The company is collaborating with @MayoClinic to test CardiAQ, a quantitative AI-powered magnetocardiography (MCG) device that captures the heart's magnetic signals. It may provide clinicians clearer insights without invasive procedures.

The company has a portfolio of investments.

Humanoid robots working commercial shifts at BMW, built at Figure's own production facility.

Parkway Venture Capital tops the latest Stanford ranking of U.S. emerging venture firms. The firm leads in performance metrics among its peers, according to the study’s methodology. The ranking highlights Parkway’s growth and influence in early-stage investment within the U.S. venture ecosystem.

Oct 2026GlobeNewswireNews article

Humanoid robotics company Figure raises a Series C round exceeding $1 billion at a $39 billion valuation. Led by Parkway Venture Capital, the round includes Brookfield Asset Management, Nvidia, and Intel Capital among its participants. Figure says it will use the funding to expand its humanoid robot fleet, build infrastructure for faster robot training, and launch advanced data collection efforts.

Sep 2025TechCrunchNews article

Parkway Venture Capital and Arcapita have formed a strategic partnership to expand their investment capabilities and regional reach. The collaboration aims to combine their expertise in venture capital and private equity. Both firms will leverage their combined networks to identify and support high-growth opportunities in emerging markets.

Jan 2025GlobeNewswireNews article

Figure secures $70 million in Series A funding to advance its humanoid robot, Figure 01. The capital will accelerate development, expand AI-driven autonomous operations, and prepare for commercial deployment. Parkway Venture Capital leads the round, with additional participation from investors including Brett Adcock and Aliya.

May 2023PR NewswireNews article